Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RNTX will decline by -4.59% over the next 2 Weeks and hit $0.85 by Tuesday, August 4, 2026. In that time frame, RNTX's share price is expected to range between $0.78 and $0.92.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 4, 2026 | 0.78 | 0.85 | 0.92 |
| Aug 3, 2026 | 0.78 | 0.85 | 0.92 |
| Jul 31, 2026 | 0.79 | 0.85 | 0.92 |
| Jul 30, 2026 | 0.77 | 0.84 | 0.91 |
| Jul 29, 2026 | 0.77 | 0.85 | 0.91 |
| Jul 28, 2026 | 0.79 | 0.86 | 0.93 |
| Jul 27, 2026 | 0.79 | 0.86 | 0.93 |
| Jul 24, 2026 | 0.79 | 0.86 | 0.93 |
| Jul 23, 2026 | 0.78 | 0.84 | 0.92 |
| Jul 22, 2026 | 0.79 | 0.85 | 0.92 |
RNTX shares fell -3.88% in Wednesday, July 22, 2026's trading session, dropping from a previous close of $0.89 to move at $0.86. The stock demonstrated notable intraday movement (see RNTX's key stats for a full breakdown), fluctuating between $0.86 and $0.90, a +5.13% trading range. While recent weeks have seen some volatility, RNTX has managed to secure a -11.33% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 594.02K shares changing hands, 24.69K more than the previous session. This amounted to $510.92K in total market activity.
Will RNTX Continue Its Upward Trend?
According to analyst ratings and projections for RNTX, Rein Therapeutics Inc. shares are anticipated to increase by +6.35%, potentially reaching $0.92 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for RNTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the RNTX stock forecast, now is a good time to buy RNTX stock because its current trading price is +0.75% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RNTX covering social and institutional perspectives.
RNTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RNTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.02% to 41.91%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.37%, maintains a neutral outlook for the long term. Insights into RNTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Rein Therapeutics Short-Term Forecasts
RNTX Forecast For Next 5 Days
Our algorithm anticipates Rein Therapeutics (RNTX) stock could hit $0.71 by Jul 29, 2026. This represents a -16.89% rise from today's price, following a +4.35% change over the past five days.
RNTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Rein Therapeutics Inc. (RNTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.62, which would mean a -27.92% decrease from the current price of $0.86. Projections for this period range from a high of $0.91 to a low of $0.31.
RNTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Rein Therapeutics's price over the next three months point to a rise. RNTX stock is expected to peak at $16.65 on Sep 16, 2026 after potentially dipping to $7.07 on Jul 27, 2026. On average, RNTX is likely to trade around $11.22 in the coming 90 days.
Rein Therapeutics Stock Forecast 2025
Based on our predictive models, Rein Therapeutics (RNTX) is expected to trade between $7.07 and $16.65 throughout 2026. This would result in an average price of $11.15, potentially offering investors a +1,196.36% return from current levels.
Rein Therapeutics Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Rein Therapeutics Inc. (RNTX) is positioned to show a strong performance in July 2026. The price is predicted to move between $7.07 and $8.15, settling at an average of $7.39. This could translate to a +759.20% gain.
August 2026
Based on current market signals, Rein Therapeutics Inc. is projected to trend august 2026. We forecast a trading range from $8.96 to $13.29, with a likely average price of $10.27. Investors could expect a potential return of +1,094.05%.
September 2026
Our predictive algorithms indicate Rein Therapeutics Inc. stock may see a shift in September 2026. The expected range spans $10.83–$16.65, with an average target of $14.76. This represents a positive outlook and a possible gain of +1,616.08%.
October 2026
Analyzing established trends, Rein Therapeutics Inc. looks set to move in October 2026. Projections place the stock between $7.95 and $10.65, averaging around $9.20. This suggests a +969.64% gain from current levels.
November 2026
Market indicators suggest Rein Therapeutics Inc. could experience notable changes during November 2026. Prices could fluctuate within $8.70 to $13.31, with a midpoint forecast of $10.95. The stock might deliver a +1,173.11% gain.
December 2026
Forecasting for December 2026, models estimate that Rein Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.68 and $14.93, averaging $11.86. This signals a positive trajectory with potential returns around +1,278.91%.
January 2027
According to our latest forecast models, Rein Therapeutics Inc. (RNTX) is positioned to show a strong performance in January 2027. The price is predicted to move between $14.34 and $23.67, settling at an average of $17.26. This could translate to a +1,906.74% gain.
February 2027
Based on current market signals, Rein Therapeutics Inc. is projected to trend february 2027. We forecast a trading range from $18.24 to $26.56, with a likely average price of $23.32. Investors could expect a potential return of +2,611.31%.
March 2027
Our predictive algorithms indicate Rein Therapeutics Inc. stock may see a shift in March 2027. The expected range spans $12.17–$19.23, with an average target of $15.65. This represents a positive outlook and a possible gain of +1,719.56%.
April 2027
Analyzing established trends, Rein Therapeutics Inc. looks set to move in April 2027. Projections place the stock between $13.28 and $24.79, averaging around $19.32. This suggests a +2,146.25% gain from current levels.
May 2027
Market indicators suggest Rein Therapeutics Inc. could experience notable changes during May 2027. Prices could fluctuate within $10.61 to $17.46, with a midpoint forecast of $12.92. The stock might deliver a +1,402.15% gain.
June 2027
Forecasting for June 2027, models estimate that Rein Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $13.69 and $23.01, averaging $16.36. This signals a positive trajectory with potential returns around +1,802.10%.
July 2027
According to our latest forecast models, Rein Therapeutics Inc. (RNTX) is positioned to show a strong performance in July 2027. The price is predicted to move between $16.42 and $24.48, settling at an average of $20.74. This could translate to a +2,311.35% gain.
RNTX's history of dividends and stock splits also plays a role in long-term investor confidence.